Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 16 Aug 2023

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

in Respiratory Pharmacology

Götz Schmidt
Gerrit Rienas
Sabrina Müller
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155930

1,638 views
2 citations

Original Research

Published on 16 Aug 2023

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

in Respiratory Pharmacology

Ling Sun
Ya-Fei Chang
Yun-Fei Wang
Xian-Zhong Ran
Xiang-Rong Li
Quan-Xin Xie
Bin Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123945

2,225 views

Original Research

Published on 16 Aug 2023

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

in Respiratory Pharmacology

Zhenping Wu
Siying Zhang
Yelin Cao
Qiyu Wang
Keyuan Sun
Xia Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209063

3,149 views
5 citations

Editorial

Published on 15 Aug 2023

Editorial: Case reports in respiratory pharmacology 2022

in Respiratory Pharmacology

Przemyslaw Zdziarski
Luisa Ricciardi
Roberto Paganelli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242273

2,277 views
2 citations

Review

Published on 07 Aug 2023

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

in Respiratory Pharmacology

Hehua Guo
Jiazheng Sun
Siyu Zhang
Yalan Nie
Sirui Zhou
Yulan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205948

13,295 views
24 citations

Review

Published on 03 Aug 2023

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

in Respiratory Pharmacology

Peng Pi
Zhipeng Zeng
Liqing Zeng
Bing Han
Xizhe Bai
Shousheng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218059

6,469 views
16 citations

Clinical Trial

Published on 28 Jul 2023

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

in Respiratory Pharmacology

Xiaobo Yang
Yun Tang
Ruofei Du
Yuan Yu
Jiqian Xu
Jiancheng Zhang
Hong Liu
Xiaojing Zou
Lehao Ren
Shiying Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139872

4,023 views
3 citations

Correction

Published on 26 Jul 2023

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

in Respiratory Pharmacology

Wenjiang Zheng
Ting Wang
Peng Wu
Qian Yan
Chengxin Liu
Hui Wu
Shaofeng Zhan
Xiaohong Liu
Yong Jiang
Hongfa Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256022

1,364 views

Review

Published on 19 Jul 2023

Recent advances in nanoparticle applications in respiratory disorders: a review

in Respiratory Pharmacology

Mohammad Ehsan Taghavizadeh Yazdi
Mohsen Qayoomian
Sima Beigoli
Mohammad Hossein Boskabady

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1059343

10,191 views
47 citations

Case Report

Published on 17 Jul 2023

Case report: Lung transplantation for treatment of paraquat intoxication: timing of transplantation

in Respiratory Pharmacology

Congcong Li
Hongfei Cai
Fanyu Meng
Fanjie Meng
Ze Tang
Ying Tang
Ying Chen
Youbin Cui
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205689

3,278 views
7 citations

Editorial

Published on 13 Jul 2023

Editorial: Coronavirus disease (COVID-19): mechanistic basic, translational, and clinical research aimed at identification of effective preventive and therapeutic strategies

in Respiratory Pharmacology

Paolo Montuschi
Fatih M. Uckun
Alastair George Stewart
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1247765

1,125 views

Original Research

Published on 13 Jul 2023

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass

in Respiratory Pharmacology

Marialena Mouzaki
Annie Dupuis
Julie Avolio
Katherine Griffin
Felix Ratjen
Elizabeth Tullis
Tanja Gonska

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1157459

4,125 views
11 citations

Original Research

Published on 13 Jul 2023

The clinical characteristics and treatment response of patients with chronic obstructive pulmonary disease with low body mass index

in Respiratory Pharmacology

Qing Song
Aiyuan Zhou
Ling Lin
Xueshan Li
Wei Cheng
Cong Liu
Yating Peng
Yuqin Zeng
Rong Yi
Yi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1131614

2,422 views
5 citations

Original Research

Published on 04 Jul 2023

Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis

in Respiratory Pharmacology

Young Jo Yoo
Seulgi Jeon
Hee Jin
Hee Yeon Won
Mi Gyeong Jeong
Yeseul Cho
Eun Sook Hwang
Younghwa Na
Jaeho Cho
Yun-Sil Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203033

3,245 views
5 citations

Clinical Trial

Published on 27 Jun 2023

Effects of the Chinese herbal formula San-Huang Gu-Ben Zhi-Ke treatment on stable chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled trial

in Respiratory Pharmacology

Tianyi Lyu
Demin Li
Xiang Lei
Yuteng Zhang
Shilei Cheng
Xinyang Shu
Hongchun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164818

5,197 views
2 citations

Original Research

Published on 21 Jun 2023

NRICM101 ameliorates SARS-CoV-2–S1-induced pulmonary injury in K18-hACE2 mice model

in Respiratory Pharmacology

Wen-Chi Wei
Keng-Chang Tsai
Chia-Ching Liaw
Chun-Tang Chiou
Yu-Hwei Tseng
Geng-You Liao
Yu-Chi Lin
Wen-Fei Chiou
Kuo-Tong Liou
I-Shing Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1125414

3,793 views
5 citations